"The IAP Antagonist Debio 1143 Enhances Chemoradiotherapy in HNSCC."

LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Debio 1143 plus chemoradiotherapy improved head and neck squamous cell carcinoma disease control. Click to show full abstract

Debio 1143 plus chemoradiotherapy improved head and neck squamous cell carcinoma disease control.

Keywords: antagonist debio; 1143 enhances; debio; chemoradiotherapy; debio 1143; iap antagonist

Journal Title: Cancer discovery
Year Published: 2020

Link to full text (if available)

Share on Social Media: Sign Up to like & get
recommendations!
1

LAUSR

You are not signed in:

Sign Up!

Related content

More Information News Social Media Video Recommended